HighTower Advisors
HURA icon

HighTower Advisors’s TuHURA Biosciences HURA Stock Holding History

HighTower Advisors’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$63K Sell
30,002
-149
-0.5% -$324 ﹤0.01% 3729
2026
Q2 		$70.6K Buy
30,151
+8,999
+43% +$21K ﹤0.01% 3693
2026
Q1 		$37.9K Buy
+21,152
New +$25.9K ﹤0.01% 3730

Other funds holding HURA

Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Apollon Wealth Management
Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Hurlow Wealth Management Group
Hurlow Wealth Management Group Bloomington, Indiana $480M AUM 12.37% 1-Year Est. Return
Schwarz Dygos Wheeler Investment Advisors
Schwarz Dygos Wheeler Investment Advisors Minneapolis, Minnesota $528M AUM 17.47% 1-Year Est. Return
Brighton Jones LLC
Brighton Jones LLC Seattle, Washington $5.73B AUM 24.99% 1-Year Est. Return

HighTower Advisors's HURA Position: Q3 2026 in Review

HighTower Advisors reduced its TuHURA Biosciences (HURA) stake by 0.49% in Q3 2026, selling an estimated $324 and leaving 30,002 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #3729.

HighTower Advisors first reported a position in HURA in Q1 2026 and has held it in 3 quarters since. The position peaked at $70.6K in Q2 2026. 41 funds tracked by Wall St. Rank hold HURA as of Q3 2026.

  • HighTower Advisors held 30,002 shares of TuHURA Biosciences worth $63K as of Q3 2026.
  • HighTower Advisors sold 149 TuHURA Biosciences shares in Q3 2026, an estimated $324.
  • TuHURA Biosciences made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3729 holding.
  • HighTower Advisors first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 3 quarters since.
  • HighTower Advisors's TuHURA Biosciences position peaked at $70.6K in Q2 2026.
  • 41 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.